MDLZ Q2 2026 Earnings — Income Statement Breakdown
For its Q2 2026 period (ending 2026-06-30), MDLZ reported revenue of $9.4B, gross profit of $4.0B (42.6% gross margin), operating income of $1.9B, and net income of $1.5B (16.5% net margin). The flow of revenue into costs and profit is visualized below.
What changed
MDLZ was profitable; revenue fell 4.0% quarter over quarter.
| Comparison | Revenue | Net income | Net margin |
|---|---|---|---|
| Year over year | Not available | Not available | Not available |
| Quarter over quarter | −4.0% | +108.3% | +8.9 pp |
Consensus estimate data is not available for this report.
MDLZ Q2 2026 Income Statement
| Line item | Amount (USD) | % of revenue |
|---|---|---|
| Revenue | $9.4B | 100% |
| Cost of Revenue | −$5.4B | 57.4% |
| Gross Profit | $4.0B | 42.6% |
| Research & Development | — | 0.0% |
| Selling, General & Administrative | −$2.0B | 21.4% |
| Other Operating Expenses | −$39M | 0.4% |
| Operating Income | $1.9B | 20.8% |
| Other Income, net | −$34M | 0.4% |
| Income Tax Expense | −$364M | 3.9% |
| Net Income | $1.5B | 16.5% |
Source: original SEC filing (filed 2026-07-28). Accession 0001628280-26-050157. Data normalized by EarningsFyi.